CIK 0001649094 · Large accelerated filer
Vaxcyte, Inc.
Sign in to watch- Ticker
- PCVX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464233385
- Phone
- 650-837-0111
- Business address
- 825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA, 94070
- Former names
- SutroVax, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,185,988
- in 8 filings, $4.8M under 10b5-1 plans
Net −$5,185,988. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −2,323 | $66.53 | $155K | 218,966 |
| 2024-04-01 | Wassil Jim CHIEF OPERATING OFFICER | Sale 10b5-1 | −677 | $67.23 | $46K | 218,289 |
| 2024-04-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −984 | $66.52 | $65K | 147,686 |
| 2024-04-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −324 | $67.27 | $22K | 147,362 |
| 2024-04-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −890 | $66.45 | $59K | 147,780 |
| 2024-04-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −415 | $67.24 | $28K | 147,365 |
| 2024-04-01 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −3 | $68.10 | $204 | 147,362 |
| 2024-03-25 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise 10b5-1 | +15,000 | $1.79 | $27K | 492,847 |
| 2024-03-25 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −13,450 | $66.87 | $899K | 479,397 |
| 2024-03-25 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Sale 10b5-1 | −1,550 | $67.50 | $105K | 477,847 |
| 2024-03-25 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (Right to Buy) 10b5-1 | −15,000 | 15,225 | ||
| 2024-03-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise 10b5-1 | +8,000 | $5.35 | $43K | 103,679 |
| 2024-03-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −7,764 | $69.00 | $536K | 95,915 |
| 2024-03-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Sale 10b5-1 | −236 | $69.64 | $16K | 95,679 |
| 2024-03-18 | GUGGENHIME ANDREW PRESIDENT AND CFO | Option exercise · Stock Option (right to buy) 10b5-1 | −8,000 | 368,827 | ||
| 2024-03-15 | Wassil Jim CHIEF OPERATING OFFICER | Grant or award | +4,099 | 222,773 | ||
| 2024-03-15 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes | −1,484 | $69.70 | $103K | 221,289 |
| 2024-03-11 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise | +65,000 | $2.03 | $132K | 477,847 |
| 2024-03-11 | PICKERING GRANT CHIEF EXECUTIVE OFFICER | Option exercise · Stock Option (right to buy) | −65,000 | 227,327 | ||
| 2024-03-02 | Wassil Jim CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −2,178 | $71.55 | $156K | 218,674 |
Page 30 of 39 · 764 trades